WP
VBIV

WealthSource Partners’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

WealthSource Partners’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,067
Closed -$27.9K – 531
2023
Q1 		$27.9K Sell
3,067
-103
-3% -$1.46K ﹤0.01% 484
2022
Q4 		$37.2K Sell
3,170
-233
-7% -$4.11K ﹤0.01% 474
2022
Q3 		$72K Sell
3,403
-84
-2% -$2.27K 0.01% 476
2022
Q2 		$85K Sell
3,487
-1,296
-27% -$44.1K 0.01% 497
2022
Q1 		$238K Buy
+4,783
New +$236K 0.02% 506

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WealthSource Partners's VBIV Position: Q2 2023 in Review

WealthSource Partners sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 3,067 shares — an estimated $27.9K sold.

WealthSource Partners first reported a position in VBIV in Q1 2022 and held it in 5 quarters. The position peaked at $238K in Q1 2022. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • WealthSource Partners reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • WealthSource Partners sold 3,067 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $27.9K.
  • WealthSource Partners first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2022 and held it in 5 quarters.
  • WealthSource Partners's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $238K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on WealthSource Partners's 13F filing for Q2 2023, filed 15 Aug 2023.